VALYSTR · Stock research
Listed on NYSE. What the market is pricing into Arcus Biosciences, Inc. (RCUS) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Pharmaceutical Preparations · market value about $2.4B · revenue $117M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows